Literature search results

566 articles were found.

The following terms were included: Glia, Gliazellen, Neuroglia, "glial cells", 神経膠細胞, 神経膠

• 2019, Vornoli A, Falcioni L, Mandrioli D, Bua L, Belpoggi F
  [details] The Contribution of In Vivo Mammalian Studies to the Knowledge of Adverse Effects of Radiofrequency Radiation on Human Health [review]
  Int J Environ Res Public Health 16 (18): E3379
• 2019, Toms SA, Kim CY, Nicholas G, Ram Z
  Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial [med. app.]
  J Neurooncol 141 (2): 467-473
• 2019, Vienne-Jumeau A, Tafani C, Ricard D
  [details] Environmental risk factors of primary brain tumors: A review [review]
  Rev Neurol 175 (10): 664-678
• 2019
  [Tumour-treating fields in addition to current standard therapy for glioblastoma as first-line treatment] [info]
  Institute for Quality and Efficiency in Health Care (IQWiG), Rapid Report N18-02 Version 1.1, IQWiG-Berichte – Nr. 772: 1-62
• 2019, Mishima T, Nagai T, Yahagi K, Akther S, Oe Y, Monai H, Kohsaka S, Hirase H
  Transcranial Direct Current Stimulation (tDCS) Induces Adrenergic Receptor-Dependent Microglial Morphological Changes in Mice [med. app.]
  eNeuro 6 (5): 1-12
• 2019, Guo L, Xue YZ, Lin JJ, An GZ, Zhang JP, Zhang KY, He W, Wang H, Li W, Ding GR
  Effects of 220 MHz Radiofrequency Field on Sperm Quality of SD Rat [med./bio.]
  2019 IEEE MTT-S International Microwave Biomedical Conference (IMBioC), Nanjing, China. IEEE: pp. 1-4; ISBN 978-1-5386-7396-6
• 2019, Cobbs C, McClay E, Duic JP, Nabors LB, Morgan DM, Kesari S
  An early feasibility study of the Nativis Voyager® device in patients with recurrent glioblastoma: first cohort in US [med. app.]
  CNS Oncol 8 (1): CNS30
• 2019, Murphy M, Dowling A, Thien C, Priest E, Morgan Murray D, Kesari S
  A feasibility study of the Nativis Voyager® device in patients with recurrent glioblastoma in Australia [med. app.]
  CNS Oncol 8 (1): CNS31
• 2019, Isaković J, Gorup D, Mitrečić D
  [details] Molecular mechanisms of microglia- and astrocyte-driven neurorestoration triggered by application of electromagnetic fields [review]
  Croat Med J 60 (2): 127-140
• 2019, Merla C, Liberti M, Consales C, Denzi A, Apollonio F, Marino C, Benassi B
  Evidences of plasma membrane-mediated ROS generation upon ELF exposure in neuroblastoma cells supported by a computational multiscale approach [med./bio.]
  Biochim Biophys Acta Biomembr 1861 (8): 1446-1457
• 2019, García-Minguillán López O, Jiménez Valbuena A, Maestú Unturbe C
  Significant Cellular Viability Dependence on Time Exposition at ELF-EMF and RF-EMF In Vitro Studies [med./bio.]
  Int J Environ Res Public Health 16 (12): e2085
• 2019, Ahmadi-Zeidabadi M, Akbarnejad Z, Esmaeeli M, Masoumi-Ardakani Y, Mohammadipoor-Ghasemabad L, Eskandary H
  Impact of extremely low-frequency electromagnetic field (100 Hz, 100 G) exposure on human glioblastoma U87 cells during Temozolomide administration [med./bio.]
  Electromagn Biol Med 38 (3): 198-209
• 2019, Natukka T, Raitanen J, Haapasalo H, Auvinen A
  Incidence trends of adult malignant brain tumors in Finland, 1990-2016 [epidem.]
  Acta Oncol 58 (7): 990-996
• 2019, Xiong L, Wang F, Qi Xie X
  Advanced treatment in high-grade gliomas [basics]
  J BUON 24 (2): 424-430
• 2019, Zorzo C, Higarza SG, Méndez M, Martínez JA, Pernía AM, Arias JL
  High frequency repetitive transcranial magnetic stimulation improves neuronal activity without affecting astrocytes and microglia density [med. app.]
  Brain Res Bull 150: 13-20
• 2019, Riley MM, San P, Lok E, Swanson KD, Wong ET
  The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma [med. app.]
  J Vis Exp (146): e58937
• 2019, Xu W, Sun J, Le Y, Chen J, Lu X, Yao X
  Effect of pulsed millisecond current magnetic field on the proliferation of C6 rat glioma cells [med./bio.]
  Electromagn Biol Med 38 (3): 185-197
• 2019, Sekar S, Zhang Y, Miranzadeh Mahabadi H, Parvizi A, Taghibiglou C
  Low-Field Magnetic Stimulation Restores Cognitive and Motor Functions in the Mouse Model of Repeated Traumatic Brain Injury: Role of Cellular Prion Protein [med. app.]
  J Neurotrauma 36 (22): 3103-3114
• 2019, Cullen CL, Senesi M, Tang AD, Clutterbuck MT, Auderset L, O'Rourke ME, Rodger J, Young KM
  Low-intensity transcranial magnetic stimulation promotes the survival and maturation of newborn oligodendrocytes in the adult mouse brain [med. app.]
  Glia 67 (8): 1462-1477
• 2019, Bunn SJ, Lai A, Li J
  DC Electric Fields Induce Perpendicular Alignment and Enhanced Migration in Schwann Cell Cultures [med./bio.]
  Ann Biomed Eng 47 (7): 1584-1595
• 2019, Cui M, Ge H, Zeng H, Yan H, Zhang L, Feng H, Chen Y
  Repetitive Transcranial Magnetic Stimulation Promotes Neural Stem Cell Proliferation and Differentiation after Intracerebral Hemorrhage in Mice [med. app.]
  Cell Transplant 28 (5): 568-584
• 2019, López-Álvarez VM, Cobianchi S, Navarro X
  Chronic electrical stimulation reduces hyperalgesia and associated spinal changes induced by peripheral nerve injury [med. app.]
  Neuromodulation 22 (5): 509-518
• 2019, Yang WJ, Wen HZ, Zhou LX, Luo YP, Hou WS, Wang X, Tian XL
  After-effects of repetitive anodal transcranial direct current stimulation on learning and memory in a rat model of Alzheimer's disease [med. app.]
  Neurobiol Learn Mem 161: 37-45
• 2019, Nilsson J, Järås J, Henriksson R, Holgersson G, Bergström S, Estenberg J, Augustsson T, Bergqvist M
  No Evidence for Increased Brain Tumour Incidence in the Swedish National Cancer Register Between Years 1980-2012 [epidem.]
  Anticancer Res 39 (2): 791-796
• 2019, Neuhaus E, Zirjacks L, Ganser K, Klumpp L, Schüler U, Zips D, Eckert F, Huber SM
  Alternating Electric Fields (TTFields) Activate Cav1.2 Channels in Human Glioblastoma Cells [med./bio.]
  Cancers 11 (1): E110
• 2019, Fiorentini G, Sarti D, Milandri C, Dentico P, Mambrini A, Fiorentini C, Mattioli G, Casadei V, Guadagni S
  Modulated Electrohyperthermia in Integrative Cancer Treatment for Relapsed Malignant Glioblastoma and Astrocytoma: Retrospective Multicenter Controlled Study [med. app.]
  Integr Cancer Ther 18: 1534735418812691
• 2019, Olsson A, Bouaoun L, Auvinen A, Feychting M, Johansen C, Mathiesen T, Melin B, Lahkola A, Larjavaara S, Villegier AS, Byrnes G, Deltour I, Schüz J
  Survival of glioma patients in relation to mobile phone use in Denmark, Finland and Sweden [epidem.]
  J Neurooncol 141 (1): 139-149
• 2019, de Vocht F
  Analyses of temporal and spatial patterns of glioblastoma multiforme and other brain cancer subtypes in relation to mobile phones using synthetic counterfactuals [epidem.]
  Environ Res 168: 329-335
• 2019, Hardell L, Carlberg M
  Comments on the US National Toxicology Program technical reports on toxicology and carcinogenesis study in rats exposed to whole-body radiofrequency radiation at 900 MHz and in mice exposed to whole-body radiofrequency radiation at 1,900 MHz [comment]
  Int J Oncol 54 (1): 111-127
• 2019, Melnick RL
  Commentary on the utility of the National Toxicology Program study on cell phone radiofrequency radiation data for assessing human health risks despite unfounded criticisms aimed at minimizing the findings of adverse health effects [comment]
  Environ Res 168: 1-6
• 2018, Hong I, Garrett A, Maker G, Mullaney I, Rodger J, Etherington SJ
  Repetitive low intensity magnetic field stimulation in a neuronal cell line: a metabolomics study [med./bio.]
  PeerJ 6: e4501
• 2018, Seo N, Lee SH, Ju KW, Woo J, Kim B, Kim S, Jahng JW, Lee JH
  Low-frequency pulsed electromagnetic field pretreated bone marrow-derived mesenchymal stem cells promote the regeneration of crush-injured rat mental nerve [med./bio.]
  Neural Regen Res 13 (1): 145-153
• 2018, Latchoumane CV, Jackson L, Sendi MSE, Tehrani KF, Mortensen LJ, Stice SL, Ghovanloo M, Karumbaiah L
  Chronic Electrical Stimulation Promotes the Excitability and Plasticity of ESC-derived Neurons following Glutamate-induced Inhibition In vitro [med./bio.]
  Sci Rep 8: 10957
• 2018, Kaszuba-Zwoinska J, Nowak B, Guzdek P, Gil K
  Cell viability changes in cultured H4 glioma cells upon low frequency pulsed electromagnetic field (7Hz, 30mT) exposure in flow cytometry analysis [med./bio.]
  2018 EMF-Med 1st World Conference on Biomedical Applications of Electromagnetic Fields (EMF-Med), Split, Croatia. IEEE: pp. 1-2; ISBN 978-1-5386-5922-9
• 2018, Taphoorn MJB, Dirven L, Kanner AA, Lavy-Shahaf G, Weinberg U, Taillibert S, Toms SA, Honnorat J, Chen TC, Sroubek J, David C, Idbaih A, Easaw JC, Kim CY, Bruna J, Hottinger AF, Kew Y, Roth P, Desai R, Villano JL, Kirson ED, Ram Z, Stupp R
  Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical Trial [med. app.]
  JAMA Oncol 4 (4): 495-504
• 2018, Keinan-Boker L, Friedman E, Silverman BG
  Trends in the incidence of primary brain, central nervous system and intracranial tumors in Israel, 1990-2015 [epidem.]
  Cancer Epidemiol 56: 6-13
• 2018, Anthony P, McArdle S, McHugh M
  Tumor Treating Fields: Adjuvant Treatment for High-grade Gliomas [basics]
  Semin Oncol Nurs 34 (5): 454-464
• 2018, Chang E, Patel CB, Pohling C, Young C, Song J, Flores TA, Zeng Y, Joubert LM, Arami H, Natarajan A, Sinclair R, Gambhir SS
  Tumor treating fields increases membrane permeability in glioblastoma cells [med./bio.]
  Cell Death Discov 4: 113
• 2018, Karipidis K, Elwood M, Benke G, Sanagou M, Tjong L, Croft RJ
  Mobile phone use and incidence of brain tumour histological types, grading or anatomical location: a population-based ecological study [epidem.]
  BMJ Open 8 (12): e024489
• 2018, Jo Y, Kim EH, Sai S, Kim JS, Cho JM, Kim H, Baek JH, Kim JY, Hwang SG, Yoon M
  Functional Biological Activity of Sorafenib as a Tumor-Treating Field Sensitizer for Glioblastoma Therapy [med./bio.]
  Int J Mol Sci 19 (11): E3684
• 2018, Ouadah NS, Lecomte A, Robidel F, Olsson A, Deltour I, Schüz J, Blazy K, Villégier AS
  Possible effects of radiofrequency electromagnetic fields on in vivo C6 brain tumors in Wistar rats [med./bio.]
  J Neurooncol 140 (3): 539-546
• 2018, Smeds H, Wales J, Mathiesen T, Talbäck M, Feychting M
  Occurrence of primary brain tumors in cochlear implant patients in Sweden between 1989 and 2014 [epidem.]
  Clin Epidemiol 10: 1401-1405
• 2018, Mirza FA, Shamim MS
  [details] Tumour Treating Fields (TTFs) for recurrent and newly diagnosed glioblastoma multiforme [review]
  J Pak Med Assoc 68 (10): 1543-1545
• 2018, Miller AB, Morgan LL, Udasin I, Davis DL
  Cancer epidemiology update, following the 2011 IARC evaluation of radiofrequency electromagnetic fields (Monograph 102) [review]
  Environ Res 167: 673-683
• 2018, Jeong YJ, Son Y, Han NK, Choi HD, Pack JK, Kim N, Lee YS, Lee HJ
  Impact of Long-Term RF-EMF on Oxidative Stress and Neuroinflammation in Aging Brains of C57BL/6 Mice [med./bio.]
  Int J Mol Sci 19 (7)
• 2018, Vila J, Turner MC, Gracia-Lavedan E, Figuerola J, Bowman JD, Kincl L, Richardson L, Benke G, Hours M, Krewski D, McLean D, Parent ME, Sadetzki S, Schlaefer K, Schlehofer B, Schüz J, Siemiatycki J, van Tongeren M, Cardis E, INTEROCC Study Group
  Occupational exposure to high-frequency electromagnetic fields and brain tumor risk in the INTEROCC study: An individualized assessment approach [epidem.]
  Environ Int 119: 353-365
• 2018, Petrella RA, Mollica PA, Zamponi M, Reid JA, Xiao S, Bruno RD, Sachs PC
  3D bioprinter applied picosecond pulsed electric fields for targeted manipulation of proliferation and lineage specific gene expression in neural stem cells [med./bio.]
  J Neural Eng 15 (5): 056021
• 2018, Narvaez CJ, Mall SK, Fountain A, Parr BA, Chittur SV, Kokorin BI, Botsford SF, Startari JF
  Specifically Targeted Electromagnetic Fields Arrest Proliferation of Glioblastoma Multiforme U-87 Cells in Culture [med./bio.]
  Anticancer Res 38 (6): 3255-3266
• 2018, Amiri M, Basiri M, Eskandary H, Akbarnejad Z, Esmaeeli M, Masoumi-Ardakani Y, Ahmadi-Zeidabadi M
  Cytotoxicity of carboplatin on human glioblastoma cells is reduced by the concomitant exposure to an extremely low-frequency electromagnetic field (50 Hz, 70 G) [med./bio.]
  Electromagn Biol Med 37 (3): 138-145
• 2018, Di Sebastiano AR, Deweyert A, Benoit S, Iredale E, Xu H, de Oliveira C, Wong E, Schmid S, Hebb MO
  Preclinical outcomes of Intratumoral Modulation Therapy for glioblastoma [med./bio.]
  Sci Rep 8: 7301